David L. DaPonte – RIVERO MESTRE LLP | Miami + New York Attorneys | International Law | Commercial Litigation

Law360 Discusses Rivero Mestre’s Trailblazing Settlement in Hep C Class Action

Rivero Mestre LLP — Fri, 19 Jun 2020 13:34:47 +0000

MIAMI—Law360 reported on Rivero Mestre’s exceptional result in obtaining $141 million worth of life-saving treatment for a class of 1500 hepatitis C sufferers in a settlement with Centene Corp.

In June 2018, Rivero Mestre sued Centene Corporation, Inc. (Centene), for failing to provide members of the class with the cure that would save their lives—Harvoni. Centene—the largest health insurer in the multistate marketplace for individual health insurance policies created under the Patient Protection and Affordable Care Act—had set up pretextual guidelines that resulted in the denial of Harvoni coverage for patients suffering from the most acute cases of hepatitis C. In addition to the $141 million of insurance coverage, the settlement also provides a fund to pay for insurance coverage for a subset of persons no longer insured by Centene so that they can obtain the treatment they need.

“The settlement is an outstanding achievement that will literally save lives,” said Rivero Mestre partner Charlie Whorton. “We are proud of the hard and creative work our team did to achieve this result.”

Click here to read the full article.

About Rivero Mestre LLP

Rivero Mestre, from its offices in Miami and New York, represents clients from investigation to verdict and appeal in complex business disputes in U.S. federal courts, state courts, and domestic and international arbitration proceedings. The firm’s practice focuses primarily on representing clients in a broad range of complex commercial disputes including financial institution matters, antitrust matters, intellectual property disputes, and litigation and arbitration relating to Latin American trade and investment. For more information, visit www.riveromestre.com?utm_source=rss&utm_medium=rss.

The post Law360 Discusses Rivero Mestre’s Trailblazing Settlement in Hep C Class Action appeared first on RIVERO MESTRE LLP | Miami + New York Attorneys | International Law | Commercial Litigation.

Law360 Discusses Rivero Mestre’s Lawsuit Against Gilead Sciences

Rivero Mestre LLP — Fri, 17 Jan 2020 15:56:12 +0000

MIAMI—On January 16, 2020, Rivero Mestre LLP filed a lawsuit against Gilead Sciences Inc. for conspiring with other drug makers to block the use of generics in HIV treatment regimens as part of an elaborate scheme that relied on anti-competitive agreements with Bristol-Myers Squibb Co., Janssen Pharmaceuticals, and Japan Tobacco. At issue are pricey “cocktail” drugs that treat HIV with combinations of multiple active ingredients, including key ingredients controlled by Gilead. The scheme enabled Gilead and its co-conspirators to unlawfully extend patent protection for their drugs, impair entry by generic competitors, and charge exorbitant, supra-competitive prices for the drugs that people living with HIV need to survive.“We think this is the classic pay-for-delay situation,” Mestre said. “We’ve been harmed, and the third-party payors we represent have been harmed, and we intend to recover for them.”

Click here to see the full article.

MSP Recovery Claims is represented by Andrés Rivero, Jorge A. Mestre, Alan H. Rolnick, Charles Whorton and David DaPonte.

About Rivero Mestre LLP

The post Law360 Discusses Rivero Mestre’s Lawsuit Against Gilead Sciences appeared first on RIVERO MESTRE LLP | Miami + New York Attorneys | International Law | Commercial Litigation.